This was reported for the human pancreatic cancer cell line PANC-1, which has an inherently high expression of YAP and in which the use of YAP RNAi simultaneously reduced YAP expression and invasive capacity. The gene discussed is YAP1; the disease is familial pancreatic carcinoma.